JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 25 June 2008

Journal of Molecular Endocrinology 2008;41:187.

Journal of Molecular Endocrinology (2008) In press  DOI: 10.1677/JME-08-0006
© 2008 Society for Endocrinology

This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JME-08-0006v1
41/3/187    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyblom, H.
Right arrow Articles by Bergsten, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyblom, H.
Right arrow Articles by Bergsten, P.

Research

AMPK agonist AICAR dose-dependently improves function and reduces apoptosis in glucotoxic β-cells without changing triglyceride levels

Hanna Nyblom, Ernest Sargsyan and Peter Bergsten

H Nyblom, Medical Cell Biology, Uppsala University, Uppsala, 75123, Sweden
E Sargsyan, Medical Cell Biology, Uppsala University, Uppsala, Sweden
P Bergsten, Medical Cell Biology, Uppsala University, Uppsala, Sweden

Correspondence: Hanna Nyblom, Email: Hanna.Nyblom{at}mcb.uu.se

Abstract

Prolonged hyperglycaemia leads to impaired glucose-stimulated insulin secretion (GSIS) and apoptosis in insulin-producing β-cells. The detrimental effects have been connected with glucose-induced lipid accumulation in the β-cell. AMP-activated protein kinase (AMPK) agonist 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) promotes utilization of nutrient stores for energy production. It was tested how impaired GSIS and elevated apoptosis observed in INS-1E cells after prolonged culture at 27 mM glucose was affected by inclusion of 0.3 or 1 mM AICAR during culture. Glucose-induced impairment of insulin release was reverted by inclusion of 0.3 but not 1 mM AICAR, which did not affect insulin content. The glucose-induced rise in triglyceride content observed in cells cultured at 27 mM glucose was not altered by inclusion of either 0.3 or 1 mM AICAR. Inclusion of 1 but not 0.3 mM AICAR during culture induced phosphorylation of AMPK and its down-stream target acyl-CoA carboxylase. Phosphorylation was paralleled by reduced number of apoptotic cells and lowered expression of pro-apoptotic protein CHOP. In conclusion, AICAR dose-dependently improves β-cell function and reduces apoptosis in β-cells exposed to prolonged hyperglycaemia without changing triglyceride levels.




This article has been cited by other articles:


Home page
HypertensionHome page
A. Zulli, E. Lau, B. P.P. Wijaya, X. Jin, K. Sutarga, G. D. Schwartz, J. Learmont, P. J. Wookey, A. Zinellu, C. Carru, et al.
High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia
Hypertension, June 1, 2009; 53(6): 1017 - 1022.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.